In a previous study, we demonstrated that OSA might reduce both static and dynamic insulin secretion without affecting whole‐body insulin sensitivity,23 which would reduce rather than increase plasma insulin levels. The gene discussed is INS; the disease is obstructive sleep apnea syndrome.